Within three to four years, the oral small-molecule sub-class is likely to have at least one or two more approved members, and price competition will start to put pressure on the injectables in cash-pay and lower-income markets
Every batch of GHK-Cu (50mg) + Epithalon (10mg) Bundle is tested for purity and identity using industry-standard methods
In addition to growing the generics business we are primarily going to focus on tough-to-make kind of products where you need to crack relatively more complex science, and primarily on the GLP-1 products, Israeli said
For the in vitro infection studies with M
April 2026 Category 2 Update On April 15, 2026, the FDA confirmed removal of injectable GHK-Cu from Category 2 because the original nominations were withdrawn
Some of these products have been traced to overseas manufacturing facilities operating without pharmaceutical-grade quality controls